BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 18300813)

  • 21. Clinical characteristics of clear cell carcinoma of the ovary.
    Behbakht K; Randall TC; Benjamin I; Morgan MA; King S; Rubin SC
    Gynecol Oncol; 1998 Aug; 70(2):255-8. PubMed ID: 9740700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spindle cell mural nodules in cystic ovarian mucinous tumors. A clinicopathologic and immunohistochemical study of five cases.
    Nichols GE; Mills SE; Ulbright TM; Czernobilsky B; Roth LM
    Am J Surg Pathol; 1991 Nov; 15(11):1055-62. PubMed ID: 1656803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undifferentiated carcinoma of the ovary.
    Silva EG; Tornos C; Bailey MA; Morris M
    Arch Pathol Lab Med; 1991 Apr; 115(4):377-81. PubMed ID: 1672813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion?
    Kim KR; Lee HI; Lee SK; Ro JY; Robboy SJ
    Am J Surg Pathol; 2007 Apr; 31(4):546-54. PubMed ID: 17414101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.
    Köbel M; Kalloger SE; Santos JL; Huntsman DG; Gilks CB; Swenerton KD
    Gynecol Oncol; 2010 Jan; 116(1):50-6. PubMed ID: 19822358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
    Zhao ZL; Song N; Huang QY; Liu YP; Zhao HR
    Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome.
    Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M
    Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
    Baker PM; Oliva E; Young RH; Talerman A; Scully RE
    Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for stage I ovarian carcinoma.
    Seidman JD; Yemelyanova AV; Khedmati F; Bidus MA; Dainty L; Boice CR; Cosin JA
    Int J Gynecol Pathol; 2010 Jan; 29(1):1-7. PubMed ID: 19952945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucinous ovarian tumors with giant cell mural nodules. A report of two cases.
    Russell P; Wills EJ; Schweitzer P; Bannatyne PM
    Diagn Gynecol Obstet; 1981; 3(3):233-49. PubMed ID: 6276116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant mixed mesodermal tumor of the ovary: a report of 22 cases.
    Dictor M
    Obstet Gynecol; 1985 May; 65(5):720-4. PubMed ID: 2984621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
    Int J Gynecol Pathol; 2011 May; 30(3):218-30. PubMed ID: 21464732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A mucinous ovarian tumor with foci of anaplastic carcinoma].
    Buzzi A; Pezzica E; Crescini C
    Minerva Ginecol; 1996 Apr; 48(4):163-6. PubMed ID: 8767560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
    Carter MR; Hornick JL; Lester S; Fletcher CD
    Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.